Headline News about Cellectis S.A. ADRVia Benzinga
Cellectis Touts Positive Preliminary Data From Two Leukemia Trials
December 13, 2022
Via Benzinga
Via Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|